ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals Market Cap: 982.56M for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 168.99B |
| Lipocine, Inc. | 18.27M |
| KalVista Pharmaceuticals, Inc. | 816.07M |
| Vivos Therapeutics, Inc. | 19.50M |
| MBX Biosciences, Inc. | 961.63M |
Market Cap Related Metrics
| PS Ratio | 6.843 |
| PEG Ratio | -0.2056 |
| Price to Book Value | 6.654 |
| Price | 9.94 |
| Earnings Yield | -8.15% |
| PEGY Ratio | -0.2056 |